logo


CardioNet Appoints Two Directors to Board
Thursday, August 21, 2008 5:09 PM


Industry veterans bring product marketing and financial expertise to Board

CONSHOHOCKEN, Pa., Aug. 21 /PRNewswire-FirstCall/ -- CardioNet, Inc. (Nasdaq: BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that it has named Ronald Ahrens and Kirk Gorman to its Board of Directors. The appointments of Mr. Ahrens and Mr. Gorman increase CardioNet's Board to a total of nine members.

Arie Cohen, CardioNet President and CEO, commented, 'Ron and Kirk are tremendous additions to our Board, and we are very pleased and fortunate to have the opportunity to gain from their years of experience across a broad spectrum of healthcare and business disciplines. Their appointments, along with the recent naming of Randy Thurman as Executive Chairman, serve to further strengthen and diversify our Board as we continue to execute our growth strategy and establish CardioNet's mobile cardiac outpatient telemetry system as the best-in-class in the arrhythmia monitoring market.'

A healthcare industry veteran with over forty years of senior executive and management experience, Mr. Ahrens most recently served as President of Merck Consumer Healthcare Group Worldwide. Prior to his tenure at Merck, Mr. Ahrens held several positions within Bristol Myers Squibb, including Consumer Group President North America and President, Bristol Myers Products Division. In addition, Mr. Ahrens has held executive and management positions at Richardson Vicks and Procter & Gamble.

Mr. Ahrens has also established a strong track record on several Boards of Directors. Currently, he serves as a Non-Executive Advisor to the Board of Johnson & Johnson Merck, and is a Board member of Temptime Corporation, a privately held company that supplies vaccine vial monitors, and ULURU, Inc., an AMEX-listed specialty pharmaceutical company specializing in wound care. Previously, Mr. Ahrens was on the Boards of VIASYS Healthcare, Closure Medical Corporation, St. Ives and Alcide.

Mr. Gorman is currently Senior Vice President and Chief Financial Officer of Jefferson Health Systems, the largest hospital system in Philadelphia. Prior to Jefferson Health Systems, he was Senior Vice President and Chief Financial Officer of Universal Health Services, the country's fifth largest investor owned hospital chain, and President, Chief Financial Officer and member of the Board of Trustees of Universal Health Realty Income Trust, a NYSE-listed healthcare REIT. Mr.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Special Offers
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia